carrot carrot carrot Change Centers x cognizanti collaborators create-folder Data Science Decisive Infrastructure download download edit Email exit Facebook files folders future-of-work global sourcing industry info infographic linkedin location Mass Empowerment Mobile First our-latest-thinking pdf question-mark icon_rss save-article search-article search-folders settings icon_share smart-search Smart Sourcing icon_star Twitter Value Webs Virtual Capital workplace Artboard 1
Life Sciences

Focus on Patients, Not Just Prescriptions, to Improve Outcomes


The Challenge

The shift to patient experience and treatment outcomes in the healthcare industry means that pharmaceutical companies must put new focus on the person behind the diagnosis. Due to complex insurance rules and an upcoming expiration on its flagship drug’s patent, a large global biopharmaceutical company needed a strategy to engage patients more deeply and keep them loyal.

This pharma company valued Cognizant’s deep expertise in marketing specialty drugs and our past successful engagements. We partnered on an approach and a strategy for the company’s important initiative.


Our Approach

We helped the pharma company develop a service strategy that simplifies and streamlines patient treatment, and then we delivered the underlying infrastructure. Coordinating care created a patient experience that focuses services on the human involved in the treatment. This approach also connected the various involved parties—from insurance companies to nurses to pharmacies—to valuable information about patient care. A mobile app further empowers patients to better manage their treatment.

Support Past the Prescription Means Better Quality of Life

Cognizant helped the pharma company create a program that improves enrolled patients’ quality of life while lowering their hospitalizations and overall healthcare costs. The company benefits from continued patient loyalty and adherence to treatment plans.

$3,000

savings per year per patient on cost of care

+26%

number of days an average patient is covered by the company’s drug

26%

of health professionals using the program to prescribe more drugs


SPREAD THE WORD